Reports

15th International Meeting of the European Society of Gynecological Oncology

Ovarian Cancer: Treatment Challenges and Decision-Making

Berlin, Germany / October 28-November 1, 2007

Berlin - Ovarian cancer remains the leading cause of death from gynecologic malignancies. Generally asymptomatic in its early stages, this disease is diagnosed in most women at advanced stages which correlate negatively with survival. While...

49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology

Glioblastoma Multiforme Prognosis: Improving Survival Rates

Los Angeles, California / October 28-November 1, 2007

Los Angeles -The most common brain tumour in adults, glioblastoma multiforme (GBM), accounts for almost half of all brain malignancies and has a 70% annual mortality. Few effective treatment options exist for GBM. Surgical resection...

15th United European Gastroenterology Week

Ulcerative Colitis: Maintenance of Remission and Prevention of Colorectal Cancer

Paris, France / October 27-31, 2007

Paris - In ulcerative colitis (UC), a pooled analysis of studies has associated 5-aminosalicylate (5-ASA) maintenance therapy with an almost 50% reduction in the risk of colorectal cancer. At least some of the protection provided can be...

15th United European Gastroenterology Week (UEGW)

Treatment Goals in IBD Evolve with Increasing Evidence that Mucosal Healing Is Critical to Favourable Long-term Outcome

Paris, France / October 27-31, 2007

Paris - The improvement in outcome associated with biologic therapies over other treatment options in inflammatory bowel disease (IBD) is being increasingly attributed to the greater likelihood of mucosal healing. In Crohn’s disease and...

15th United European Gastroenterology Week (UEGW)

Ulcerative Colitis: Promising New Findings for Rapid Symptom Relief

Paris, France / October 27-31, 2007

Paris - The lack of compliance to maintenance therapies in ulcerative colitis, particularly once symptoms have been controlled, has long been regarded as a major cause of relapses and complications. The recent introduction of a q.d....

15th United European Gastroenterology Week

Maintaining Remission Without Increasing Treatment Burden: Expanding Therapeutic Options

Paris, France / October 27-31, 2007

Editorial Overview: Brian G. Feagan, MD, FRCPC Once reserved for inflammatory bowel disease (IBD) refractory to other options, tumour necrosis factor alpha (TNF-a) inhibitors are being considered earlier in the treatment of...

11th European AIDS Conference

Pharmacogenetics: Treating the Individual AIDS Patient

Madrid, Spain / October 24-27, 2007

Currently, the goal of HIV therapy is to achieve sustained viral suppression and the extent to which this is achieved depends on both viral and host factors. Viral factors include viral sensitivity, viral load and viral subtype. In the case...

Canadian Cardiovascular Congress 2007

High-risk Concept: Management Paradigm Shift from Treatment to Prevention

Quebec City, Quebec / October 20-24, 2007

Quebec City - Better stratification of cardiovascular (CV) risk in asymptomatic patients is becoming increasingly urgent due to the evidence that effective treatments can change the natural history of vascular diseases. In patients with...

Canadian Cardiovascular Congress 2007

The Pillars of ACS Treatment: Assess Risk, Address Ischemia, Prevent Bleeding, Protect Long-Term

Quebec City, Quebec / October 20-24, 2007

Quebec City - Appropriate treatment of acute coronary syndromes (ACS) requires a comprehensive assessment of the patient’s risk for further ischemia and cardiovascular events. Inadequate attention to risk stratification can lead to...